TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30777736

Group type: EXPERIMENTAL
Intervention: Mandibular distraction osteogenesis (MDO)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sagittal split ramus osteotomy (SSRO)
Number of subjects: 18
Study: 28082176

Group type: EXPERIMENTAL
Intervention: Combined tDCS (2 mA, 10 daily sessions of 20 minutes) and VRT
Number of subjects: 7

Group type: COMPARATOR
Intervention: Standard rehabilitation with compensatory eye movement and exploration training (Control)
Number of subjects: 7
Study: 25624343

Group type: EXPERIMENTAL
Intervention: Prediabetes mellitus and hypertension combined group
Number of subjects: 1609

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus and hypertension combined group
Number of subjects: 1609

Group type: EXPERIMENTAL
Intervention: Blood glucose level within prediabetic range
Number of subjects: 1609
Study: 24758078

Group type: EXPERIMENTAL
Intervention: Ginkgo Leaves Tablet (GLT), 19.2 mg each time, three times daily for 12 months
Number of subjects: 113

Group type: COMPARATOR
Intervention: Dietetic therapy and physical exercises (Control)
Number of subjects: 113
Study: 21098343

Group type: EXPERIMENTAL
Intervention: Complete program (multimedia patient education program with trained health professional follow-up)
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: Materials only (multimedia patient education materials alone)
Number of subjects: 1206

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 1206
Study: 19066982

Group type: EXPERIMENTAL
Intervention: Parecoxib
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 17572317

Group type: EXPERIMENTAL
Intervention: GlideScope videolaryngoscope (GSVL)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Macintosh direct laryngoscope (MDLS)
Number of subjects: 57
Study: 12947008

Group type: EXPERIMENTAL
Intervention: Treosulfan 10 g/m2 intravenously daily for 3 days and fludarabine 30 mg/m2 intravenously daily for 5 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Treosulfan and fludarabine regimen
Number of subjects: 30
Study: 11432888

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus carboplatin (PC)
Number of subjects: 408

Group type: COMPARATOR
Intervention: Vinorelbine plus cisplatin (VC)
Number of subjects: 408
Study: 11783299

Group type: EXPERIMENTAL
Intervention: Salvia miltiorrhiza composita (SMC) administered intravenously during the operation
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Salvia miltiorrhiza composita (SMC)
Number of subjects: 108
Study: 7797786

Group type: EXPERIMENTAL
Intervention: Prophylactic treatment group (maternal avoidance of cow's milk, egg, and peanut during pregnancy and lactation; infant avoidance of cow's milk until age 1, egg until age 2, and peanut and fish until age 3)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control group (maternal/infant pairs following standard feeding practices)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Children with food allergy by age 4 years
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Atopic diseases/parameters at age 7 years
Number of subjects: 165
Study: 2162439

Group type: COMPARATOR
Intervention: Cisplatin (CDDP) alone
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: CDDP plus vindesine (VDS) (CV-1)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: CDDP plus VDS (CV-2)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: CDDP plus VDS plus mitomycin (MMC) (CVM)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: CDDP plus etoposide alternating with VDS plus MMC (CE/VM)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Overall comparison of treatments
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Overall response to chemotherapy
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Responders to chemotherapy
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Overall conclusion
Number of subjects: 345
Study: 387151

Group type: EXPERIMENTAL
Intervention: High dose flupenthixol decanoate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard dose flupenthixol decanoate
Number of subjects: 0
Study: 30273016

Group type: EXPERIMENTAL
Intervention: Oral nutrition supplementation (ONS) for 7 days before surgery
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no oral nutrition supplementation)
Number of subjects: 66
Study: 26811519

Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m2 and cisplatin 75 mg/m2 plus concurrent thoracic radiation therapy (60 to 66 Gy) followed by consolidation pemetrexed every 3 weeks for four cycles (arm A)
Number of subjects: 598

Group type: COMPARATOR
Intervention: Etoposide 50 mg/m2 and cisplatin 50 mg/m2 plus concurrent thoracic radiation therapy (60 to 66 Gy) followed by two cycles of consolidation platinum-based doublet chemotherapy (arm B)
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: Pemetrexed-cisplatin (arm A)
Number of subjects: 598

Group type: COMPARATOR
Intervention: Etoposide-cisplatin (arm B)
Number of subjects: 598
Study: 23807185

Group type: EXPERIMENTAL
Intervention: Vitrectomy with silicone oil tamponade
Number of subjects: 81

Group type: COMPARATOR
Intervention: Fellow eyes (control)
Number of subjects: 81
Study: 21929838

Group type: EXPERIMENTAL
Intervention: Berry meal (150 g purée of bilberries, blackcurrants, cranberries, and strawberries with 35 g sucrose)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Berry meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control meal (sucrose in water)
Number of subjects: 12
Study: 20075014

Group type: EXPERIMENTAL
Intervention: Verum acupuncture (performed at Large Intestine 4 on the dorsal right hand for 30 minutes)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo acupuncture (validated sham acupuncture)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Expectations for change in pain
Number of subjects: 40
Study: 17904817

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 15731694

Group type: EXPERIMENTAL
Intervention: Fibrin glue applied to one side of the face
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (unglued side)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fibrin glue
Number of subjects: 30
Study: 14644214

Group type: EXPERIMENTAL
Intervention: 0.2% brimonidine for 4 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Vehicle control (not explicitly mentioned in the abstract)
Number of subjects: 17
Study: 10656534

Group type: EXPERIMENTAL
Intervention: Choto-san (in both studies)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Water extract of Uncaria sinensis (US)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Glutamate (control for US)
Number of subjects: 199
Study: 9038463

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 0.3 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 60
Study: 1523447

Group type: EXPERIMENTAL
Intervention: Vialon catheter material
Number of subjects: 772

Group type: COMPARATOR
Intervention: Teflon catheter material
Number of subjects: 772
Study: 6610283

Group type: EXPERIMENTAL
Intervention: Students with consent (n=358)
Number of subjects: 604

Group type: COMPARATOR
Intervention: Students without consent
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Both groups (with and without consent)
Number of subjects: 604
Study: 2856702

Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 0
Study: 31396745

Group type: EXPERIMENTAL
Intervention: Onco-Move (home-based physical activity program)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: OnTrack (supervised exercise program with home-based component)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: OnTrack (supervised exercise program)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Onco-Move and OnTrack (both programs)
Number of subjects: 153
Study: 30261306

Group type: EXPERIMENTAL
Intervention: Hypertonic saline solution (HSS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Oxygen (O2, control exposure)
Number of subjects: 20
Study: 27113241

Group type: EXPERIMENTAL
Intervention: 3D intervention
Number of subjects: 1383

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1383
Study: 25202997

Group type: COMPARATOR
Intervention: Mental practice
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Physical practice
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mental-physical practice
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Physical-mental practice
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 22546132

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 147

Group type: COMPARATOR
Intervention: Open appendectomy
Number of subjects: 147
Study: 19875744

Group type: EXPERIMENTAL
Intervention: Maximum Cure (MC) on dry enamel
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Multilink Sprint (MLS) on dry enamel
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Maximum Cure (MC) on wet enamel
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Multilink Sprint (MLS) on wet enamel
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Adhesive Remnant Index (ARI) scores for MC and MLS
Number of subjects: 40
Study: 18544724

Group type: EXPERIMENTAL
Intervention: Bright light (+/- 1000 lux)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Melatonin (2.5 mg)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Combined treatment (bright light + melatonin)
Number of subjects: 189
Study: 15780736

Group type: EXPERIMENTAL
Intervention: High-dose combined hepatitis A and B vaccine administered in two doses (0, 6 months)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Paediatric-dose combined hepatitis A and B vaccine administered in three doses (0, 1, 6 months)
Number of subjects: 100
Study: 14504024

Group type: EXPERIMENTAL
Intervention: Three-session motivational enhancement therapy (MET alone)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Three-session MET plus contingency management (MET/CM)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Both MET and MET/CM
Number of subjects: 65
Study: 10953189

Group type: EXPERIMENTAL
Intervention: Cerebral glucose uptake in patients with mitochondrial disorders
Number of subjects: 15

Group type: COMPARATOR
Intervention: Cerebrovascular vasoreactivity to acetazolamide stimulation
Number of subjects: 15
Study: 8844560

Group type: EXPERIMENTAL
Intervention: Intensive smooth speech
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive electromyography feedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home-based smooth speech
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 0
Study: 1627421

Group type: EXPERIMENTAL
Intervention: Breast-conserving therapy (lumpectomy, axillary clearance, and radiotherapy to the breast: 50 Gy external irradiation in 5 weeks followed by boost with iridium implant of 25 Gy)
Number of subjects: 903

Group type: COMPARATOR
Intervention: Mastectomy
Number of subjects: 903
Study: 6744790

Group type: EXPERIMENTAL
Intervention: Dopamine infusion at 0.01 micrograms min‐1 kg‐1
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Dopamine infusion at 0.1 micrograms min‐1 kg‐1
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (NaCl solution 154 mmol/l)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Dopamine infusion (both rates)
Number of subjects: 7
Study: 30819460

Group type: EXPERIMENTAL
Intervention: Personalized system of instruction (PSI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 29242000

Group type: EXPERIMENTAL
Intervention: Social recovery therapy plus early intervention services
Number of subjects: 155

Group type: COMPARATOR
Intervention: Early intervention services alone
Number of subjects: 155
Study: 27221557

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 16
Study: 25142068

Group type: EXPERIMENTAL
Intervention: BMMC
Number of subjects: 39

Group type: COMPARATOR
Intervention: Vehicle medium (Control)
Number of subjects: 39
Study: 22210105

Group type: EXPERIMENTAL
Intervention: Negative mood induction procedure (experimental group)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Neutral mood procedure (control group)
Number of subjects: 45
Study: 19873927

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 1017
Study: 17173659

Group type: EXPERIMENTAL
Intervention: Home-based (HB) education plus clinic-based (CB) education
Number of subjects: 132

Group type: COMPARATOR
Intervention: Clinic-based (CB) education alone
Number of subjects: 132
Study: 16382061

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 8010

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 8010
Study: 11976161

Group type: EXPERIMENTAL
Intervention: xoi gac (3.5 mg beta-carotene per serving)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: rice mixed with synthetic beta-carotene powder (5.0 mg)
Number of subjects: 185

Group type: COMPARATOR
Intervention: rice without fortification (control)
Number of subjects: 185
Study: 11206587

Group type: EXPERIMENTAL
Intervention: Cirrhotic patients with prolonged latencies of P3a and/or P3b
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Cirrhotic patients with prolonged NCT
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Cirrhotic patients
Number of subjects: 39

Group type: COMPARATOR
Intervention: Normal adult subjects
Number of subjects: 39
Study: 8890080

Group type: EXPERIMENTAL
Intervention: Commercial available preterm infant formula (2% protein, 40 mg glycine/dl)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Glycine-rich protein formula (2% protein, 130 mg glycine/dl)
Number of subjects: 8
Study: 1517788

Group type: EXPERIMENTAL
Intervention: IL-3 (days 1 to 5 subcutaneously) and GM-CSF (day 6 to 15 subcutaneously)
Number of subjects: 36

Group type: COMPARATOR
Intervention: GM-CSF alone or no hematopoietic growth factors (Control)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: IL-3 and GM-CSF
Number of subjects: 36
Study: 6391269

Group type: EXPERIMENTAL
Intervention: Fentanyl infusion (2 micrograms/kg/hour)
Number of subjects: 15
Study: 30701390

Group type: EXPERIMENTAL
Intervention: Family-based intervention
Number of subjects: 721

Group type: EXPERIMENTAL
Intervention: Adolescent-only intervention
Number of subjects: 721

Group type: EXPERIMENTAL
Intervention: General health promotion intervention
Number of subjects: 721
Study: 29677689

Group type: EXPERIMENTAL
Intervention: Hearing aids (HAs) used for six months
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no HAs used during the study)
Number of subjects: 35
Study: 27032663

Group type: EXPERIMENTAL
Intervention: Self-Directed Care (SDC) intervention
Number of subjects: 60
Study: 25754567

Group type: EXPERIMENTAL
Intervention: Meta Salud intervention
Number of subjects: 0
Study: 24074777

Group type: EXPERIMENTAL
Intervention: Neoadjuvant treatment strategies for breast cancer subtypes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant treatment in HER2 positive and TNBC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Response-guided approach for hormone-positive tumors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing number of chemotherapy cycles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tryphaena study
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simultaneous application of docetaxel, doxorubicin, and cyclophosphamide for 6 cycles in TNBC
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adding bevacizumab in TNBC treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Efficacy of carboplatin in neoadjuvant trials
Number of subjects: 0
Study: 21959700

Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 76

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 76
Study: 18174880

Group type: EXPERIMENTAL
Intervention: ACEi + ARB (ramipril + candesartan)
Number of subjects: 24

Group type: COMPARATOR
Intervention: ACEi + Ca-A (ramipril + lercanidipine)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups (ACEi + ARB and ACEi + Ca-A)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ACEi + ARB
Number of subjects: 24
Study: 16687343

Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Microwave (MW)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Hospital length of stay (RF)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Hospital length of stay (MW)
Number of subjects: 205
Study: 14666006

Group type: EXPERIMENTAL
Intervention: Peristernal double crisscross wire closure (Group X)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Standard transsternal closure (Group T)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Both groups (X and T)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Patients with deep wound infection and sternal instability (Group T)
Number of subjects: 700
Study: 10964147

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 53

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 53
Study: 9353687

Group type: EXPERIMENTAL
Intervention: Passive ankle dorsiflexion at 5 degrees/sec
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Passive ankle dorsiflexion at 60 degrees/sec
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Passive ankle dorsiflexion at 120 degrees/sec
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Passive ankle dorsiflexion at 180 degrees/sec
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High velocity stretch (180 degrees/sec) with larger initial plantar flexor resistance
Number of subjects: 18
Study: 8258986

Group type: EXPERIMENTAL
Intervention: Ultrasound therapy (UST)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Mechanical pressure therapy (MPT)
Number of subjects: 96
Study: 2939217

Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ketanserin monotherapy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ketanserin and Metoprolol combination therapy
Number of subjects: 40
Study: 29337861

Group type: EXPERIMENTAL
Intervention: Vegetable protein meal (fava beans/split peas)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Animal protein meal (veal/pork or eggs with pea fiber)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Animal protein meal (eggs without fiber supplementation)
Number of subjects: 35
Study: 26996984

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) intervention
Number of subjects: 18

Group type: COMPARATOR
Intervention: Usual adherence education and side‐effect management (Control)
Number of subjects: 18
Study: 24655114

Group type: EXPERIMENTAL
Intervention: intra‐oesophageal infusion of acidic solution (0·1 N HCl; pH 1·2)
Number of subjects: 15

Group type: COMPARATOR
Intervention: intra‐oesophageal saline infusion
Number of subjects: 15

Group type: COMPARATOR
Intervention: no infusion
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: oesophageal acid stimulation
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: oesophageal acid infusion
Number of subjects: 15
Study: 22525653

Group type: EXPERIMENTAL
Intervention: Methylsulfonylmethane (MSM) supplementation (50 mg/kg in 200 mL water)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (200 mL water)
Number of subjects: 18
Study: 19939872

Group type: EXPERIMENTAL
Intervention: Org 26828 at 3 and 6 μg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Midazolam intravenous 0.1 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Org 26828 at doses higher than 1 μg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Org 26828 at doses up to 0.3 μg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Org 26828 at higher doses
Number of subjects: 0
Study: 18369631

Group type: EXPERIMENTAL
Intervention: Chest radiographs evaluated by radiologists
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Peribronchial cuffing in supine position
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Vascular pedicle width in supine position
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Combination of radiographic features
Number of subjects: 277

Group type: COMPARATOR
Intervention: BNP testing
Number of subjects: 277
Study: 15897952

Group type: EXPERIMENTAL
Intervention: Embolization leading to occlusion of blood vessels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Revascularization leading to reopening of blood vessels
Number of subjects: 0
Study: 12522402

Group type: EXPERIMENTAL
Intervention: Prophylactic injection of bupivacaine with adrenaline
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 40
Study: 10643842

Group type: EXPERIMENTAL
Intervention: Palivizumab (monoclonal antibody to the F protein of RSV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ELISA (enzyme-linked immunosorbent assay)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plaque assay
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inflammatory indices (white blood cell count, myeloperoxidase, eosinophilic cationic protein)
Number of subjects: 0
Study: 8851829

Group type: EXPERIMENTAL
Intervention: Group A: 10 mg/kg/h propofol and 40% O2/air (n = 14)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Group B: 1-0.7% isoflurane and 40% N2O/O2 (n = 10)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Baseline prolactin levels for Group A
Number of subjects: 35

Group type: COMPARATOR
Intervention: Baseline prolactin levels for Group B
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Postoperative prolactin levels for Group A
Number of subjects: 35

Group type: COMPARATOR
Intervention: Postoperative prolactin levels for Group B
Number of subjects: 35
Study: 7524774

Group type: EXPERIMENTAL
Intervention: Thoracoscopic approach
Number of subjects: 24

Group type: COMPARATOR
Intervention: Open supraclavicular approach
Number of subjects: 24
Study: 3365916

Group type: EXPERIMENTAL
Intervention: 500 mg diflunisal
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: 60 mg codeine
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: 500 mg diflunisal plus 60 mg codeine
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161